IE
GNCA

Israel Englander’s Genocea Biosciences, Inc. GNCA Stock Holding History

Israel Englander’s Portfolio GNCA Stock Details GNCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-420,800
Closed -$526K – 7915
2022
Q1 		$526K Buy
+420,800
New +$458K ﹤0.01% 5091

Other funds holding GNCA

ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
AICPI
ABG Innovation Capital Partners III Central, Hong Kong, Hong Kong $64.5K AUM 1.01% 1-Year Est. Return

Israel Englander's GNCA Position: Q2 2022 in Review

Israel Englander sold out of Genocea Biosciences, Inc. (GNCA) in Q2 2022, closing a stake of 215,002 shares — an estimated $269K sold.

Israel Englander first reported a position in GNCA in Q1 2015 and held it in 25 quarters. The position peaked at $6.11M in Q2 2015. 5 funds tracked by Wall St. Rank hold GNCA as of Q2 2022.

  • Israel Englander reported no remaining Genocea Biosciences, Inc. position as of Q2 2022 after selling out during the quarter.
  • Israel Englander sold 215,002 Genocea Biosciences, Inc. shares in Q2 2022, an estimated $269K.
  • Israel Englander first reported a position in Genocea Biosciences, Inc. in Q1 2015 and held it in 25 quarters.
  • Israel Englander's Genocea Biosciences, Inc. position peaked at $6.11M in Q2 2015.
  • 5 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q2 2022.

Based on Millennium Management's 13F filing for Q2 2022, filed 15 Aug 2022.